Delivery Order SPE2DB22D2007-SPE2DB25FJ3WX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,774.90 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded transaction for pharmaceutical supplies to support...
- The Defense Logistics Agency awarded a delivery order valued at $5,996.73 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract does not include a set-aside designation. Performance will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,958.04 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,939.49 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count packages) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,660.39 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count packages) with a firm fixed price structure. The contract, awarded July 31, 2025, represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 1, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This...
- The Defense Logistics Agency awarded a $15,063.99 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This competitively awarded, firm fixed-price contract was executed on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside transaction, indicating the contract was open to all qualified...
- The Defense Logistics Agency awarded a $33,081.12 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a firm fixed price ceiling value of $11,979.29. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive, non-set-aside delivery order. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,646.18 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of August 5, 2025. This contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $12,553.34 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 tablets. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3WXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,084.74 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30 count) under a firm fixed-price contract. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025. This non-set-aside contract represents a routine pharmaceutical procurement for military medical supply needs, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As the prime contractor under this IDC, AmerisourceBergen supplies a broad spectrum of pharmaceutical products and medical commodities to support military healthcare systems worldwide, including medications across multiple therapeutic domains, vaccines, and specialized medical supplies. The company's selection for this delivery order reflects its established capability to meet federal procurement requirements through competitive processes and its critical role in supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/13/25 |